{"title":"Prescribe for patients with opioid use disorder — with confidence","authors":"Alison Knopf","doi":"10.1002/cpu30890","DOIUrl":null,"url":null,"abstract":"<p>A new message from the Food and Drug Administration (FDA) encourages primary care providers to prescribe medication — primarily, buprenorphine — for opioid use disorder (OUD) “with confidence.” In the missive, subtitled “Patients with opioid use disorder need you,” the FDA noted that more than 6 million people age 12 or older have an OUD. Below is the FDA statement.</p>","PeriodicalId":22496,"journal":{"name":"The Brown University Child & Adolescent Psychopharmacology Update","volume":"26 8","pages":"8"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Child & Adolescent Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cpu30890","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
A new message from the Food and Drug Administration (FDA) encourages primary care providers to prescribe medication — primarily, buprenorphine — for opioid use disorder (OUD) “with confidence.” In the missive, subtitled “Patients with opioid use disorder need you,” the FDA noted that more than 6 million people age 12 or older have an OUD. Below is the FDA statement.